Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/1996
04/25/1996WO1996012033A1 Polycystic kidney disease gene
04/25/1996WO1996011953A1 N-terminally chemically modified protein compositions and methods
04/25/1996WO1996011945A2 Cyclic depsipeptide sulfonylation, sulfenylation and phosphorylation process
04/25/1996WO1996011938A1 Oligonucleotide and carcinostatic agent containing the same as active ingredient
04/25/1996WO1996011935A1 Metallocenic diarylethylene derivatives, methods for their preparation and pharmaceutical compositions containing same
04/25/1996WO1996011934A1 Tricyclic spiro compounds process for their preparation and their use as 5ht1d receptor antagonists
04/25/1996WO1996011933A1 Fused pyrrolocarbazoles
04/25/1996WO1996011932A1 2-(imidazol-4-yl)carbapeneme derivatives, intermediates thereof and use as antibacterials
04/25/1996WO1996011930A1 Cns-active pyridinylurea derivatives
04/25/1996WO1996011925A1 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4' (ltb4) antagonists
04/25/1996WO1996011924A1 Substituted spiroalkylamino and spiroalkoxy-heterocycles, process for preparing the same and their use as pesticides and fungicides
04/25/1996WO1996011923A1 Indole derivative for the treatment of migraine
04/25/1996WO1996011922A1 Pyrrolyl tetrahydrobenzoquinoxaline diones, their preparation and use as glutamate receptor antagonists
04/25/1996WO1996011920A1 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4 (ltb4) antagonists
04/25/1996WO1996011917A1 Novel benzoxazoles
04/25/1996WO1996011916A1 Azole derivative
04/25/1996WO1996011914A1 New carboxylic acid derivatives, their preparation and their use
04/25/1996WO1996011911A1 5-lipoxygenase inhibitors
04/25/1996WO1996011910A1 Bis-2-aminopyridines, preparation method therefor and use thereof for controlling parasitic infections
04/25/1996WO1996011908A1 Modified polyunsaturated fatty acids
04/25/1996WO1996011902A1 Pharmaceutically active substituted aromatic compounds
04/25/1996WO1996011701A1 Enteric coated compositions of 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity
04/25/1996WO1996011697A1 Thrombin inhibitors
04/25/1996WO1996011694A2 AROMATIC COMPOSITION BASED ON OLIBANAM COMBINED WITH A SYNERGIC AGENT (e.g. EUCALYPTOL, BARNEOL, ZINC, SALT, COPPER, SALT) AND USE THEREOF
04/25/1996WO1996011692A1 Use of anthocyanidin and derivatives for treatment of retroviral infections
04/25/1996WO1996011691A1 Use of 1,5-benzodiazepine derivatives for the control of gastric emptying in patients with non-insulin dependent diabetes mellitus
04/25/1996WO1996011690A1 Diazepino-indoles as phosphodiesterase iv inhibitors
04/25/1996WO1996011689A1 Use of cck-b receptor antagonists for the treatment of sleep disorders
04/25/1996WO1996011688A1 Use of zaprinast for the manufacture of a medicament for inhibiting vascular restenosis
04/25/1996WO1996011687A1 Sabeluzole oral suspensions
04/25/1996WO1996011686A1 Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid-like activity
04/25/1996WO1996011685A2 Use of indole derivatives for the treatment of various diseases
04/25/1996WO1996011684A1 Method for topical inhibition of the metabolic activity of cytochrome p-450
04/25/1996WO1996011683A1 New cytotoxic agents
04/25/1996WO1996011682A1 Preventive and remedy for type i allergic diseases
04/25/1996WO1996011681A1 Preventive and remedy for diarrhea
04/25/1996WO1996011680A2 Use of gaba agonists in the treatment of emesis
04/25/1996WO1996011678A1 Method for attenuation of sympathetic nervous system activity or onset of migraine by selectively metabolized beta-blocking agents
04/25/1996WO1996011677A1 Methods for treating resistant tumors
04/25/1996WO1996011676A1 Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases
04/25/1996WO1996011669A1 Lyophilizate of lipid complex of water insoluble camptothecins
04/25/1996WO1996011666A1 Particles including degradable material and anti-microbial agent
04/25/1996WO1996011572A1 Antimicrobial composition
04/25/1996WO1995031541A3 Methods and compositions for treatment of restenosis and cancer using ribozymes
04/25/1996WO1995030670A3 Pyranone compounds useful to treat retroviral infections
04/25/1996DE4437403A1 Antioxidant for protecting human cells from damage by free radicals
04/25/1996DE4437198A1 Verfahren zur Sulfonylierung, Sulfenylierung und Phosphorylierung von cyclischen Depsipeptiden Method for Sulfonylation, sulfenylation and phosphorylation of cyclic depsipeptides
04/25/1996DE4437140A1 Artificial nail for treatment of fungal infection
04/25/1996DE19534164A1 Medicinal use of pyrimido:triazine-di:one derivs.
04/25/1996CA2472085A1 N-terminally chemically modified protein compositions and methods
04/25/1996CA2202751A1 Cyclic depsipeptide sulfonylation, sulfenylation and phosphorylation process
04/25/1996CA2202661A1 Methods for treating resistant tumors
04/25/1996CA2202630A1 Use of zaprinast for the manufacture of a medicament for inhibiting vascular restenosis
04/25/1996CA2202623A1 Azole derivative
04/25/1996CA2202554A1 Aromatic composition on olibanam combined with a synergic agent (e.g. eucalyptol, barneol, zinc, salt, copper, salt) and use thereof
04/25/1996CA2202527A1 Sabeluzole oral suspensions
04/25/1996CA2202497A1 Particles including degradable material and anti-microbial agent
04/25/1996CA2202467A1 Use of anthocyanidin and derivatives for treatment of retroviral infections
04/25/1996CA2202459A1 Substituted spiroalkylamino and -alkoxy heterocycles, process for their preparation, and their use as pesticides and fungicides
04/25/1996CA2202389A1 Agent for preventing and treating diarrhea
04/25/1996CA2202283A1 Polycystic kidney disease gene
04/25/1996CA2202273A1 Novel benzoxazoles
04/25/1996CA2202169A1 Metallocenic diarylethylene derivatives, methods for their preparation and pharmaceutical compositions containing same
04/25/1996CA2202056A1 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4' (ltb4) antagonists
04/25/1996CA2201742A1 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4 (ltb4) antagonists
04/25/1996CA2201527A1 Pyrrolyl tetrahydrobenzoquinoxaline diones, their preparation and use as glutamate receptor antagonists
04/25/1996CA2200628A1 Diazepino-indoles as phosphodiesterase iv inhibitors
04/25/1996CA2161176A1 Heterocyclic compounds and their preparation and use
04/24/1996WO1997014681A1 Heterocyclic compounds as h+-atpases
04/24/1996EP0708111A1 17-Desoxy corticosteroid-21-esters, a process for their preparation and pharmaceutical compositions containing them
04/24/1996EP0708104A1 Process and intermediate for the preparation of terazosin hydrochloride dihydrate
04/24/1996EP0708103A1 Process for the preparation of a tetrazole derivative in two crystalline forms and a new crystalline form of this derivative
04/24/1996EP0708102A1 5-HT1F agonists for the treatment of migraine
04/24/1996EP0708101A1 Novel piperidine derivatives, useful as neurokinin receptor antagonists
04/24/1996EP0708100A1 Dibenzofurane compounds, pharmaceutical and cosmetic compositions containing them
04/24/1996EP0708099A1 Tricyclic amide compounds, process for their preparation and pharmaceutical compositions containing them
04/24/1996EP0708098A1 Oxime derivatives, their preparation and their therapeutic use
04/24/1996EP0708093A1 Quinoxalines, process for their preparation, and their use
04/24/1996EP0708088A1 Alkyl-5-methylsulphonyl-benzoyl-guanidine derivatives
04/24/1996EP0708085A2 Antiviral ethers of aspartate protease substrate isosteres
04/24/1996EP0707855A2 Combination therapy for chronic hepatitis C infection
04/24/1996EP0707854A2 Compositions for the treatment of gastronitestinal disorders containing bismuth and an antimicrobial
04/24/1996EP0707853A1 Muscle relaxant pharmaceutical compositions
04/24/1996EP0707852A2 Bicyclic bradykinin receptor antagonists
04/24/1996EP0707851A2 Benzopyran phenol derivates for use as antibacterial, antiviral or immunostimulating agents
04/24/1996EP0707850A1 Use of polyunsaturated fatty acids for the manufacture of a medicament for the treatment of brest pain
04/24/1996EP0707849A1 Use of derivatives of 2,4-bisubstituted phenols as 5-lipoxigenase inhibitors
04/24/1996EP0707848A1 Solid pharmaceutical composition comprising an excipient capable of binding water
04/24/1996EP0707847A1 Ketoprofen liposomes
04/24/1996EP0707845A2 Alkylmethylsiloxane-containing gels
04/24/1996EP0707792A1 Fungicidal combinations of active agents
04/24/1996EP0707644A1 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases
04/24/1996EP0707638A1 Regulatable nucleic acid therapeutic and methods of use thereof
04/24/1996EP0707591A1 Methylphosphonic acid ester, process for preparing the same and its use
04/24/1996EP0707587A1 Pharmacologically active enantiomers
04/24/1996EP0707586A1 Positive inotropic and lusitropic pyrroloquinolinone derivatives
04/24/1996EP0707585A1 Bicyclic tetrahydro pyrazolopyridines
04/24/1996EP0707584A1 Novel (1-heteroazolyl-1-heterocyclyl)alkane derivatives and their use as neuroprotective agents
04/24/1996EP0707583A1 Process for the preparation of thiopyrans
04/24/1996EP0707580A1 Magnesium omeprazole
1 ... 6923 6924 6925 6926 6927 6928 6929 6930 6931 6932 6933 6934 6935 6936 6937 6938 6939 6940 6941 6942 6943 ... 7860